Introduction
Materials and methods
Cell culture and imaging experiments
Gene expression microarrays and gene signatures
Statistics and data analysis
In vivo tumor studies and immunofluorescence
Results
Vascular genomic programs are highly expressed in claudin-low and basal-like tumors
The tumor-activated endothelium signature identifies proliferating vasculature
Vascular signatures add metastasis predictive information within intrinsic subtypes
Signature | Combined 855 | UNC 254 | METABRIC 1971 | MDACC493 | MERGED 550 | |||||
---|---|---|---|---|---|---|---|---|---|---|
Hazard ratio |
p-Value | Hazard ratio |
p-Value | Hazard ratio |
p-Value | Hazard ratio |
p-Value | Hazard ratio |
p-Value | |
Proliferation | 1.428 | 5.26E-02 | 1.365 | 1.61E-01 |
1.242
|
1.97E-07
| 1.186 | 2.57E-01 |
1.259
|
1.08E-02
|
Wallgard | 1.266 | 2.23E-01 | 0.913 | 8.51E-01 |
1.222
|
2.02E-02
|
1.960
|
4.73E-02
| 1.169 | 5.16E-01 |
Vascular content |
1.985
|
8.66E-05
| 1.666 | 4.23E-01 | 1.192 | 2.07E-01 | 1.274 | 4.67E-01 |
2.555
|
2.51E-04
|
Vasculogenic mimicry |
1.450
|
8.80E-04
| 1.300 | 4.53E-01 |
1.278
|
1.70E-03
|
1.570
|
2.40E-02
|
1.720
|
8.50E-04
|
VEGF hypoxia
|
1.439
|
1.73E-06
|
3.255
|
2.16E-07
|
1.262
|
1.51E-07
|
1.609
|
1.54E-02
|
1.760
|
3.45E-06
|
Tumor vascular A | 1.263 | 2.65E-01 |
0.128
|
1.46E-02
|
1.286
|
3.20E-02
|
0.291
|
6.12E-03
| 0.879 | 6.42E-01 |
Tumor Vascular B |
1.967
|
1.08E-02
| 1.081 | 8.96E-01 | 1.198 | 1.64E-01 | 0.803 | 6.07E-01 |
2.220
|
1.65E-02
|
Activated endothelium
|
2.688
|
3.40E-03
|
18.406
|
4.67E-03
|
2.262
|
1.40E-03
|
7.460
|
2.29E-03
|
7.942
|
1.76E-05
|
Act endo nonproliferation |
2.683
|
5.30E-03
|
11.021
|
2.62E-02
| 1.473 | 1.38E-01 |
11.232
|
4.82E-04
| – | – |
Act endo proliferation | 1.106 | 1.99E-01 | 1.614 | 5.96E-02 |
1.305
|
4.51E-05
| 1.035 | 8.01E-01 | – | – |